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Abstract
Background: Iodine is important for thyroid hormone synthesis, and iodine deficiency in pregnancy may
impair fetal neurological development. As perchlorate and thiocyanate inhibit sodium-iodide symporter
reducing the transport of iodine from circulation into the thyroid follicular cells, environmental exposure to
these substances in pregnancy may impair maternal thyroid hormone synthesis. We aimed to explore the
impact of perchlorate and thiocyanate exposure on thyroid status in a cohort of pregnant mothers from
South West England.
Methods: Urine samples were obtained from 308 women participating in a study of breech presentation in
late pregnancy. They had no known thyroid disease and a singleton pregnancy at 36–38 weeks gestation.
Samples were analysed for urinary concentrations of iodine (UIC), perchlorate (UPC) and thiocyanate (UTC). Blood
samples were taken for free T4 (FT4), thyrotropin (TSH) and thyroid peroxidase antibodies (TPO-Ab). Baseline data
included age, parity, smoking status, ethnicity and BMI at booking. Following delivery, data on offspring’s sex,
gestational age at birth and birthweight were collected.
Results: Participants had a mean (SD) age 31 (5) years, median (IQR) BMI 24.4 (22.0, 28.3) kg/m2, 42% were primiparous,
10% were smokers, and 96% were Caucasian. Median UIC was 88 μg/l, and 174/308 (57%) women had UIC < 100 μg/l.
Log transformed UPC negatively correlated with FT4, but not with TSH, in the whole cohort (r = − 0.12, p = 0.03) and in
the subgroup of women with UIC < 100 μg/l (r = − 0.15, p = 0.04). Regression analysis with the potential confounders
(TPO-Ab status, UIC and UTC) identified UPC to be negatively associated with FT4 (p = 0.01). There was no correlation
between UTC and FT4 or TSH. Maternal UPC or UTC was not associated with offspring birthweight.
Conclusion: Environmental perchlorate exposure is negatively associated with circulating FT4 levels in third trimester
pregnant women. This may have an adverse impact on neurocognitive development of the fetus.
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Background
Optimal level of maternal thyroid hormone in pregnancy
is important for fetal neurological development, and as
iodine is an essential component of thyroid hormone,
iodine deficiency in pregnancy may impair fetal neuro-
logical development [1]. In recent years, there has been
increasing concern that exposure to environmental pol-
lutants during pregnancy may result in reduced maternal
thyroid hormone synthesis affecting fetal neurodevelop-
ment [2, 3].
Perchlorate and thiocyanate are common environmental
pollutants that can disrupt normal thyroid function by re-
ducing the uptake of iodine from the circulation into the
thyroid follicular cells through competitive inhibition at the
sodium-iodide symporter [2]. Perchlorate can be found in
water, milk and some food crops, including green leafy veg-
etables and fruits. It was found to be present in 77 out of
342 food items tested in the UK between 2014 and 15 [4].
It is also present in fertilisers, rocket fuels, explosives, fire-
works, road flares and air bags. Cigarette smoke is the main
source of thiocyanate, but it can also be found in some veg-
etables of the Cruciferae family, such as cabbage, broccoli
and cauliflower. Perchlorate is about 15 times stronger than
thiocyanate as an inhibitor of the sodium-iodide symporter
[5], and in pharmacological doses is known to suppress thy-
roid hormone synthesis [2]. However, there is a concern
that even a low-level exposure of perchlorate or thiocyanate
could disrupt thyroid hormone synthesis, particularly in the
presence of iodine deficiency. This could lead to health
hazards that may be more pronounced in vulnerable pop-
ulations, such as pregnant women. Several studies have
examined the effect of perchlorate and thiocyanate expos-
ure during pregnancy on maternal thyroid function, how-
ever these showed conflicting results, and the potential
adverse impact of exposure remains controversial [6–12].
Therefore, we aimed to study the impact of perchlo-
rate and thiocyanate exposure on thyroid function of
pregnant mothers from South West England where iod-
ine deficiency has been shown to be common [13].
Methods
Participants
We studied 308 women participating in a study of
breech presentation in late pregnancy [14]. They were
recruited during routine antenatal care at the Royal
Devon and Exeter Hospital (RD&E), a secondary care
hospital in South-West England serving a population of
about 450,000. They had a singleton pregnancy at 36–
38 weeks gestation. They had no known thyroid disease,
and were not on any drugs which may affect thyroid
function. We collected baseline clinical data (including
age, parity, smoking status, ethnicity and body mass
index (BMI) at booking), and blood and spot urine sam-
ples from the participants. Following delivery, we
collected data on sex, gestational age at birth and
birth-weight of the babies; these data were unavailable
for one baby as their mother moved away out of area be-
fore delivery.
Sample analysis
Blood samples were analysed at the RD&E Blood Sci-
ences department for serum thyroid stimulating hormone
(TSH), free thyroxine (FT4) and thyroid peroxidase anti-
bodies (TPO-Ab) using the electrochemiluminescent im-
munoassay, run on the Modular E170 Analyser (Roche,
Burgess Hill, UK). Intra-assay coefficients of variations
were < 5.3% for both TSH and FT4. The manufacturer’s
population reference ranges were: TSH 0.35–4.5 mIU/l
and FT4 11–24 pmol/l. Serum TPO-Ab titre above 34 IU/
l was considered positive.
Urine samples were analysed for iodine, perchlorate, and
thiocyanate concentration using ion chromatography-mass
spectrometry at the Iodine Research Laboratory (Boston
University, Boston, Massachusetts) [15]. The inter-assay co-
efficient of variation ranges from 3.1–8.2% for the three
analytes.
Statistical analysis
We assessed variables for normal distribution and log
transformed (log) where appropriate. Where this did not
result in a normal distribution, these data are presented
as median (IQR). Correlations between two variables
were assessed and results presented as Pearson correl-
ation coefficients. Regression analysis was undertaken to
identify independent predictors of thyroid status. As iod-
ine deficiency may aggravate the effect of perchlorate
and thiocyanate exposure, we also carried out subgroup
analyses in women with urinary iodine concentration
(UIC) less than 100 μg/l.
Table 1 Baseline Characteristics for total cohort (n = 308)
Characteristics Figures
Age (years)a 31(5)
Booking BMI (kg/m2)b 24.4 (22.0, 28.3)
Gestation (weeks)b 37.0 (36.1, 37.6)
Primiparous 128 (42%)
Smoking 31 (10%)
Caucasian 295 (96%)
TSH (mIU/l)b 1.9 (1.4, 2.6)
Free T4 (pmol/l)a 12.0 (1.6)
TPO-Ab positive 16/305 (5%)
Urinary Iodine (μg/l)b 88 (55, 157)
Urinary Perchlorate (μg/l)b 2.1 (1.4,3.8)
Urinary Thiocyanate (μg/l)b 436 (302,683)
Data presented as amean (SD), b median (IQR) or (n) %
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We analysed correlations between offspring birthweight
(corrected for sex and gestational age at birth) and mater-
nal urinary perchlorate concentration (UPC) and urinary
thiocyanate concentration (UTC). We also carried out
subgroup analyses considering birthweight (corrected for
gestational age) of male and female infants separately.
With a sample size of 300, we can detect correlation
coefficients r ≥ 0.12 as statistically significant at p < 0.05.
Statistical analysis was undertaken using SPSS (ver-
sion 22).
Results
Baseline characteristics
Baseline clinical characteristics and thyroid function
of the 308 participants are shown in Table 1.
Ninety-six percent were Caucasian. The median UIC
was 88 μg/l [13]. Fifty-seven percent (174 out of
308) women had UIC below 100 μg/l. The median
UPC was 2.1 μg/l (IQR 1.4–3.8, range 0.3–143), and
the median UTC was 436 μg/l (IQR 302–683, range
29–3290).
Fig. 1 Correlations between log urinary perchlorate (Panels a and b) and thiocyanate (Panels c and d) with thyroid status
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Correlation between urinary perchlorate and maternal
thyroid status
Log UPC was negatively correlated with FT4 (r = − 0.12, p
= 0.03) but not with log TSH (r = − 0.01, p = 0.9) (Fig. 1,
Panels a and b). In the subgroup of women with UIC less
than 100 μg/l, log UPC remained negatively correlated
with FT4 (r = − 0.15, p = 0.04) but not with log TSH.
Correlation between urinary thiocyanate and maternal
thyroid status
There was no correlation between log UTC and FT4
(r = 0.08, p = 0.15) or log TSH (r = − 0.08, p = 0.17)
(Fig. 1, Panels c and d). Likewise, in the subgroup of
women with UIC less than 100 μg/l, there was no correl-
ation between log UTC and FT4 (r = 0.08, p = 0.17) or log
TSH (r = − 0.08, p = 0.17).
Multivariate analysis to assess the impact of potential
confounders
We carried out multiple regression analysis to assess the
impact of potential confounders (TPO-Ab, UIC, UPC
and UTC). Maternal smoking was not included in the
regression analysis because of its collinearity with thio-
cyanate levels (significant correlation between maternal
smoking and log UTC, r = 0.4, p < 0.001). The regres-
sion analysis showed that only log UPC was signifi-
cantly independently associated with FT4, with higher
UPC associated with lower serum FT4 (β = − 0.29,
95% CI -0.52 to − 0.07, p = 0.01) (Table 2). The
addition of smoking to the multivariable regression
analysis did not change the association. The regres-
sion coefficient (β) of − 0.29 suggests that for every
10% increase in UPC, there will be a 0.03 pmol/l de-
crease in serum FT4.
Table 2 Regression analyses demonstrating the relationships between urinary perchlorate concentration and other potential
confounding variables on serum FT4 and TSH (n = 308)
β SE 95% CI for β t p
Factors associated with serum FT4
Urinary perchloratea −0.291 0.114 (− 0.515, − 0.066) −2.55 0.01
Urinary iodinea 0.156 0.124 (−0.088, 0.401) 1.27 0.21
Urinary thiocyanatea 0.196 0.127 (−0.053, 0.446) 1.55 0.12
TPO antibody positive −0.345 0.413 (−1.156, 0.467) −0.84 0.4
Factors associated with serum TSHa
Urinary perchloratea 0.008 0.032 (−0.056, 0.071) 0.24 0.8
Urinary iodinea −0.03 0.035 (−0.10, 0.039) −0.85 0.4
Urinary thiocyanatea −0.047 0.036 (−0.117, 0.24) −1.31 0.2
TPO antibody positive 0.248 0.117 (0.02, 0.48) 2.126 0.03
aDenotes variable transformed using natural logs (allowing β coefficients to be interpreted in terms of percentage change)
Bold values are significant result in the table
Table 3 Regression analyses demonstrating the relationships between urinary perchlorate concentration and other potential
confounding variables on serum FT4 and TSH in a subgroup of women with UIC < 100 μg/l (n = 174)
β SE 95% CI for β t p
Factors associated with serum FT4
Urinary perchloratea −0.33 0.166 (−0.655, 0.001) −1.97 0.05
Urinary iodinea 0.153 0.308 (−0.455, 0.762) 0.50 0.6
Urinary thiocyanatea 0.184 0.170 (−0.151, 0.520) 1.09 0.3
TPO-Ab positive −0.316 0.512 (−1.328, 0.70) −0.616 0.54
Factors associated with serum TSHa
Urinary perchloratea 0.04 0.043 (−0.046, 0.125) 0.91 0.4
Urinary iodinea −0.06 0.081 (−0.214, 0.104) −0.68 0.5
Urinary thiocyanatea −0.044 0.044 (−0.131, 0.044) −0.98 0.3
TPO-Ab positive 0.257 0.134 (−0.01, 0.52) 1.92 0.06
aDenotes variable transformed using natural logs (allowing â coefficients to be interpreted in terms of percentage change)
Bold value is significant result in the table
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Only TPO Ab positive was an independent predictor
of serum TSH (Table 2). UPC or UTC was not an inde-
pendent predictor of serum TSH.
The multiple regression analysis in the subgroup of
women with UIC less than 100 μg/l also showed that log
UPC was borderline significantly independently associated
with serum FT4, with higher UPC associated with lower
serum FT4 (β = − 0.33, 95% CI -0.66 to 0.001, p = 0.05)
(Table 3). UPC or UTC was not an independent predictor
of serum TSH.
Effect of maternal perchlorate and thiocyanate exposure
on offspring birthweight
There was no correlation between maternal UPC and off-
spring birthweight (r= − 0.07, p = 0.2 for the whole cohort;
r = − 0.04, p = 0.6 for the subgroup of women with UIC less
than 100 μg/l) or between maternal UTC and infant birth-
weight (r = 0, p = 1.0 for the whole cohort; r = 0.03, p = 0.7
for the subgroup of women with UIC less than 100 μg/l).
Subgroup analyses using birthweight (corrected for gesta-
tional age) of male and female infants separately also failed
to show association between offspring birthweight and ma-
ternal UPC (r = − 0.09, p = 0.3) or maternal UTC (r = 0.09,
p = 0.3).
Discussion
Our study has shown that environmental exposure to per-
chlorate and thiocyanate is ubiquitous and the exposure
to perchlorate is associated with lower circulating FT4
levels in third trimester pregnant women. We did not
identify an association between exposure to thiocyanate in
pregnancy and maternal thyroid hormone. Maternal ex-
posure of perchlorate or thiocyanate was not associated
with offspring’s birthweight.
Previous studies examining association between per-
chlorate exposure and maternal thyroid function in
Table 4 Studies assessing the association between urinary perchlorate concentration and maternal thyroid status in pregnancy
Author (year) Country N Gestation Median UIC
(μg/l)
Median UPC (range)
(μg/l)
Association of UPC with
Maternal TSH Maternal FT4
Pearce, 2010 [6] Italy 787a 1st trimester 50–55 5 (0.04–168) No No
Wales 854b 1st trimester 98–117 2 (0.02–368) No No
Pearce, 2011 [7] USA 134 1st trimester 144 7.8 (0.4–284) No No
Argentina 107 1st trimester 130 13.5 (1.1–676) No No
Pearce, 2012 [8] Greece 134 1st trimester 120 4.1 (0.2–118.5) No Yes (negative)c
Charatcharoenwitthaya, 2014 [9] Thailand 200 1st trimester 153.5 1.9 (0.1–35.5) Yes (positive) Yes (negative)
Horton, 2015 [10] USA 284 1st trimester 235 (mean)d 3.54 (mean)d Yes (positive) No
Steinmaus, 2016 [11] USA 1880 Median 7 weeks 155 6.5 (0.23–177) Yes (positive) TT4, FT4 (negative)
Mortensen, 2016 [12] USA 359 3rd trimester 167 4.04 (geometric mean) No No
This study England 308 3rd trimester 88 2.1 (0.3–143) No Yes (negative)
FT4 free T4, TSH thyroid stimulating hormone, NK not known, UIC urinary iodine concentration, UPC urinary perchlorate concentration
aIncludes 261 women with hypothyroidism/hypothyroxinaemia (median UIC 55 μg/l) and 526 euthyroid women (median UIC 50 μg/l)
bIncludes 374 women with hypothyroidism/hypothyroxinaemia (median UIC 98 μg/l) and 480 euthyroid women (median UIC 117 μg/l)
cNegative association on univariate analysis but no longer associated after adjustments in multivariate analysis
dCreatinine – adjusted (μg/g creatine)
Table 5 Studies assessing the association between urinary thiocyanate concentration and maternal thyroid status in pregnancy
Author (year) Country N Gestation Median UIC
(μg/l)
Median UTC
(range) (μg/l)
Association of UTC with
Maternal TSH Maternal FT4
Pearce, 2010 [6] Italy 787a 1st trimester 55–60 373 (132–6650) No Yes (negative)c
Wales 854b 98–117 471 (34–3100) No No
Pearce, 2012 [8] Greece 134 1st trimester 120 413 (0.6–1635) Yes (positive)d No
Charatcharoenwitthaya, 2014 [9] Thailand 200 1 s trimester 153.5 510.5 (68–3525) Yes (positive) Yes (negative)
Horton, 2015 [10] USA 284 1st trimester 235 (mean)e 1006 (mean)e No No
This study England 308 3rd trimester 88 436 (29–3290) No No
FT4 free T4, TSH thyroid stimulating hormone, NK not known, UIC urinary iodine concentration, UTC urinary thiocyanate concentration
aIncludes 261 women with hypothyroidism/hypothyroxinaemia (median UIC 55 μg/l) and 526 euthyroid women (median UIC 50 μg/l)
bIncludes 374 women with hypothyroidism/hypothyroxinaemia (median UIC 98 μg/l) and 480 euthyroid women (median UIC 117 μg/l)
cNegative correlation in the euthyroid cohort on univariate analysis
dPositive association on univariate analysis but no longer associated after adjustments in multivariate analysis
eCreatinine – adjusted (μg/g creatine)
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pregnancy have shown inconsistent results (Table 4). Al-
though some studies [6–8, 12] found no association be-
tween UPC and maternal thyroid function, others have
shown that UPC is associated with low maternal FT4 and/
or high TSH [9–11]. Possible reasons for the discrepant
results include diverse study populations, different iodine
status, and variable gestational age at the time of perchlo-
rate and thyroid function assessment. In our study, there
was a 0.03 pmol/L decrease in maternal serum FT4 level
with every 10% increase in UPC, providing additional evi-
dence to support the association between perchlorate ex-
posure and reduced maternal thyroid hormone levels.
This is in keeping with observations outside pregnancy,
where perchlorate exposure has been shown to be associ-
ated with decreased FT4 in the general population, includ-
ing non-pregnant women and adolescent girls [16, 17].
The association between perchlorate exposure during
pregnancy and reduced maternal serum FT4 could poten-
tially have important clinical implications as maternal thy-
roid hormone insufficiency has been shown to be
associated with impaired neurocognitive development of
offspring and other adverse obstetric outcomes [18, 19]. In
a recent study, pregnant women with subclinical
hypothyroidism or hypothyroxinaemia and UPC in the
upper 10% were found to have a 3-fold increased odds of
having offspring with an intelligence quotient (IQ) in the
lowest 10% at age of 3 years [20]. However, UPC was not
associated with maternal thyroid hormone status in this co-
hort. Therefore, the mechanism for the association between
maternal perchlorate exposure and reduced offspring IQ in
this study remains uncertain although it may be due to the
effect of perchlorate exposure on fetal thyroid function
[20]. Another recent study has suggested that maternal per-
chlorate exposure in pregnancy could also affect obstetric
outcomes, with maternal perchlorate exposure associated
with increased birthweight in male infants, particularly in
infants born prematurely [21]. However there was no as-
sessment of maternal thyroid function in the cohort; there-
fore it is uncertain whether the association seen was
mediated through changes in maternal thyroid hormone
levels. Our study was unable to confirm the association be-
tween maternal perchlorate exposure and offspring birth-
weight in the whole cohort as well as in the subgroup of
male infants. This is in keeping with a previous study which
also found no association between perchlorate exposure in
pregnancy and offspring’s birthweight, birth length or ges-
tational age at birth [22]. However, taken together, these
observations highlight the need for further investigations to
examine whether environmental exposure to perchlorate
during pregnancy has adverse health outcomes beyond
minor changes on maternal thyroid hormone levels.
In contrast to our findings on perchlorate exposure, we
were unable to show an association between thiocyanate
exposure and maternal thyroid hormone levels. This may
be because thiocyanate is a much weaker inhibitor of
sodium-iodine symporter as compared to perchlorate [5].
However, a small number of previous studies have sug-
gested potential effects of thiocyanate exposure on mater-
nal thyroid status [6, 8, 9] (Table 5). Furthermore, it is also
possible that co-exposure of thiocyanate with other envir-
onmental pollutants have more deleterious impact on ma-
ternal thyroid function than exposure to an individual
pollutant [10].
We acknowledge several limitations of the study: urin-
ary iodine, perchlorate and thiocyanate concentrations
were measured on a single spot urine sample, and thy-
roid hormone assessments were carried out only once.
Our cohort was predominantly Caucasian, from South
West England, thereby limiting generalisability.
Conclusions
This study provides further evidence that environmental
perchlorate exposure is associated lower circulating
serum FT4 levels in pregnant women. This may have an
adverse impact on neurocognitive development of the
fetus and other pregnancy outcomes.
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